Literature DB >> 21219852

Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1α.

Yehuda Kamari1, Aviv Shaish, Shay Shemesh, Einav Vax, Itamar Grosskopf, Shahar Dotan, Malka White, Elena Voronov, Charles A Dinarello, Ron N Apte, Dror Harats.   

Abstract

OBJECTIVE: Interleukin (IL)-1α and IL-1β are products of macrophages, endothelial cells and vascular smooth muscle cells; moreover, each of these cell types is affected by the pro-inflammatory properties of both IL-1's. Whereas several studies demonstrate the proatherogenic properties of IL-1β, the role of IL-1α in atherogenesis remains unclear. We assessed whether IL-1α and IL-1β from tissue resident vascular cells or emigrating bone marrow-derived cells promote the development of atherosclerosis in apoE-/- mice and determined the effect of selective macrophage IL-1α or IL-1β deficiency on degradation of LDL and cytokine production.
METHODS: We generated strains of double knock-out (KO) mice (apoE-/-/IL-1α-/- and apoE-/-/IL-1β-/-) and created chimeras consisting of apoE-/- mice reconstituted with bone marrow-derived cells from apoE-/-/IL-1+/+, apoE-/-/IL-1α-/- and apoE-/-/IL-1β-/-.
RESULTS: The areas of aortic sinus lesions were lower in either double KO mice compared to solely apoE-/- mice, despite higher non-HDL cholesterol levels. Importantly, selective deficiency of IL-1α or IL-1β in bone marrow-derived cells inhibited atherogenesis to the same extent as in double KO mice without affecting plasma lipids. Aortic sinus lesions in apoE-/- mice transplanted with IL-1β-/- or IL-1α-/- cells were 32% and 52% lower, respectively, than in IL-1+/+ transplanted mice. Ex vivo, isolated IL-1α-/- macrophages from atherosclerotic mice degraded LDL and secreted IL-6, TNFα and IL-12 similarly to IL-1+/+ macrophages; however, IL-1α deficient macrophages secreted reduced levels of IL-1β (-50%) and 2-3-fold higher levels of the anti-inflammatory cytokine IL-10.
CONCLUSION: We show for the first time that it is IL-1α from bone marrow-derived cells that accelerates atherogenesis in apoE-deficient mice rather than constitutive IL-1α in vascular cells, possibly by increasing the inflammatory cytokine profile of macrophages.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219852     DOI: 10.1016/j.bbrc.2011.01.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

1.  Recruitment of pro-IL-1α to mitochondrial cardiolipin, via shared LC3 binding domain, inhibits mitophagy and drives maximal NLRP3 activation.

Authors:  Jargalsaikhan Dagvadorj; Karolina Mikulska-Ruminska; Gantsetseg Tumurkhuu; Rojo A Ratsimandresy; Jessica Carriere; Allen M Andres; Stefanie Marek-Iannucci; Yang Song; Shuang Chen; Malcolm Lane; Andrea Dorfleutner; Roberta A Gottlieb; Christian Stehlik; Suzanne Cassel; Fayyaz S Sutterwala; Ivet Bahar; Timothy R Crother; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

2.  IL-1 signaling in atherosclerosis: sibling rivalry.

Authors:  Frederick J Sheedy; Kathryn J Moore
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

3.  More than inflammation: interleukin-1beta polymorphisms and the lipid metabolism.

Authors:  Mihai G Netea; Charles A Dinarello
Journal:  J Clin Endocrinol Metab       Date:  2011-05       Impact factor: 5.958

Review 4.  The role of the inflammasome in cardiovascular diseases.

Authors:  Xuan Li; Nicolas Deroide; Ziad Mallat
Journal:  J Mol Med (Berl)       Date:  2014-03-19       Impact factor: 4.599

5.  IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β.

Authors:  Youngho Lee; Daiko Wakita; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Ganghua Huang; Thomas J A Lehman; Michael C Fishbein; Hal M Hoffman; Timothy R Crother; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

6.  Intermittent PTH 1-34 administration improves the marrow microenvironment and endothelium-dependent vasodilation in bone arteries of aged rats.

Authors:  Seungyong Lee; Ashley Bice; Brianna Hood; Juan Ruiz; Jahyun Kim; Rhonda D Prisby
Journal:  J Appl Physiol (1985)       Date:  2018-02-08

7.  High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation.

Authors:  Seth G Thacker; Abdalrahman Zarzour; Ye Chen; Mustafa S Alcicek; Lita A Freeman; Dennis O Sviridov; Stephen J Demosky; Alan T Remaley
Journal:  Immunology       Date:  2016-08-28       Impact factor: 7.397

8.  Deletion of calponin 2 in macrophages alters cytoskeleton-based functions and attenuates the development of atherosclerosis.

Authors:  Rong Liu; J-P Jin
Journal:  J Mol Cell Cardiol       Date:  2016-08-26       Impact factor: 5.000

9.  Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36.

Authors:  Fenghua Zhou; Yunyun Pan; Zhiyong Huang; Yuhua Jia; Xiaoshan Zhao; Yuyao Chen; Jianxin Diao; Qiang Wan; Xiaobing Cui
Journal:  Cell Stress Chaperones       Date:  2013-03-15       Impact factor: 3.667

10.  RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality.

Authors:  Lingjun Meng; Wei Jin; Xiaodong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.